|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Deferred offering costs | ||||
| Current Assets | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Prepaid insurance, current portion | ||||
| Total Current Assets | ||||
| Prepaid insurance, non-current portion | ||||
| Cash held in Trust Account | ||||
| Total Assets | ||||
| Current Liabilities | ||||
| Accrued expenses | ||||
| Promissory note – related party | ||||
| Accounts payable and accrued expenses | ||||
| Due to Sponsor | ||||
| Total Current Liabilities | ||||
| Deferred underwriting fee | ||||
| Total Liabilities | ||||
| Commitments and Contingencies (Note 6) | ||||
| Class A ordinary shares, $0.0001 par value; 14,375,000 shares subject to possible redemption at $10.20 and $10.02 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders' deficit | ||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||||
| Ordinary shares, value | ||||
| Class A ordinary shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
